Furthermore, overexpression of BCL2, resulting from the t(14;18) chromosomal translocation in lymphomas, such as follicular lymphoma, can be used as a surrogate marker to distinguish, and enrich for, tumor cells. This evidence concerns the gene BCL2 and follicular lymphoma.